Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia Treatment

AstraZeneca bags CDSCO nod to import, market Andexanet Alfa in India

Written By Ruchika Sharma23 Jan 2024 4:45 PM IST

Bangalore: AstraZeneca Pharma India Ltd., has announced that it has received approval from Central Drugs Standard Control Organisation (CDSCO) in...

Aurobindo Pharma arm Unit IV gets 5 USFDA observations

Indoco Remedies gets USFDA EIR for oral dosage facility at Goa plant I

Written By Ruchika Sharma23 Jan 2024 2:59 PM IST

Mumbai: Indoco Remedies Limited has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (U.S. FDA) for...

Abbott Volt Pulsed Field Ablation System bags USFDA approval for atrial fibrillation

USFDA approves expanded MRI labelling for Abbott Proclaim DRG neurostimulation system for people suffering from chronic pain

Written By Ruchika Sharma23 Jan 2024 10:00 AM IST

Abbott Park, Ill.: Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved expanded MRI labeling for its dorsal root...

China Approves Amgens Tarlatamab (Imdelltra) for Advanced Small Cell Lung Cancer

USFDA adds boxed warning for Amgen bone loss drug Prolia

Written By Ruchika Sharma22 Jan 2024 2:30 PM IST

New Delhi: The U.S. Food and Drug Administration added a serious warning on the prescribing information for Amgen's drug Prolia to treat bone...

Improper storage of Insulin injections worth Rs 5 lakhs: DCA raids medical distributor

Written By Ruchika Sharma22 Jan 2024 12:30 PM IST

Hyderabad: Officials from the Drugs Control Administration (DCA), Telangana, conducted a raid on the premises of a medical distributor in Kapra,...

Pfizer Secures Vyndamax Patent Till 2031

Former Pfizer employee convicted of insider trading on COVID drug Paxlovid trial

Written By Ruchika Sharma22 Jan 2024 10:11 AM IST

A former employee of Pfizer Inc was convicted of insider trading on Thursday for buying stock options in November 2021 just before Pfizer announced...

Imbruvica gets positive EMA Committee opinion for untreated mantle cell lymphoma eligible for Stem Cell Transplant: Janssen-Cilag International

JnJ Balversa gets full USFDA nod to treat locally advanced or metastatic Bladder Cancer with Select Genetic Alterations

Written By Ruchika Sharma21 Jan 2024 4:30 PM IST

Raritan: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application...

Gurugram Bust: Rs 70 Lakh Counterfeit Eli Lilly Mounjaro Recovered, 2 Arrested

USFDA finds new manufacturing lapses at Eli Lilly plant: Report

Written By Ruchika Sharma21 Jan 2024 4:00 PM IST

U.S. inspectors recently uncovered new manufacturing problems at an Eli Lilly plant that has been under scrutiny by federal investigators, according...

Bayer new drug application for gadoquatrane accepted for review in China

Bayer Eylea 8 mg gets Japanese marketing nod

Written By Ruchika Sharma21 Jan 2024 1:00 PM IST

Berlin: Bayer has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted market authorization for Eylea 8 mg...

AstraZeneca Voydeya approved in Japan for paroxysmal nocturnal haemoglobinuria

Written By Ruchika Sharma21 Jan 2024 12:30 PM IST

Cambridge: AstraZeneca has announced that Voydeya (danicopan) has been approved in Japan for the treatment of paroxysmal nocturnal...

Havisure: India's first indigenously developed Hepatitis A vaccine launched

Written By Ruchika Sharma20 Jan 2024 2:23 PM IST

It is a two-dose vaccine wherein the first dose is administered at 12 months of age and the second dose is given at least 6 months after the first...

Shilpa Medicare gets Germany marketing authorization for Amifampridine Tablets

Written By Ruchika Sharma20 Jan 2024 12:30 PM IST

Hyderabad: Shilpa Medicare Limited has received Marketing Authorization from Germany, EU for Amifampridine Tablets, 10 mg under the National...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok